|
| CD4 (N) | p Value | CD8 (N) | p Value | ||
| Low CD4 0% - 29% | High CD4 30% - 100% |
| Low CD8 0% - 29% | High CD8 30% - 100% | ||
| Menopausal Status |
| |||||
| Premenopausal | 13 | 8 | 0.1 | 14 | 7 | 0.35 |
| postmenopausal | 20 | 4 | 19 | 5 | ||
| Pathological Subtype |
| |||||
| IDC | 32 | 12 | 0.54 | 32 | 12 | 0.54 |
| Others | 1 | 0 | 1 | 0 | ||
| Grade |
| |||||
| GII | 28 | 10 | 0.9 | 28 | 10 | 0.9 |
| GIII | 5 | 2 | 5 | 2 | ||
| Molecular Subtype |
| |||||
| Luminal A | 4 | 0 | 0.007 | 4 | 0 | 0.018 |
| Luminal B | 19 | 4 | 18 | 5 | ||
| TNBC | 6 | 2 | 7 | 1 | ||
| Her-2 | 4 | 6 | 4 | 6 | ||
| Estrogen Receptor |
| |||||
| Positive | 23 | 4 | 0.029 | 22 | 5 | 0.13 |
| Negative | 10 | 8 | 11 | 7 | ||
| Progesterone Receptor |
| |||||
| Positive | 19 | 4 | 0.15 | 18 | 5 | 0.45 |
| Negative | 14 | 8 | 15 | 7 | ||
| Ki67% |
| |||||
| <20 | 7 | 3 | 0.78 | 8 | 2 | 0.59 |
| ≥20 | 26 | 9 | 25 | 10 | ||
| Her-2 overexpression |
| |||||
| Positive | 13 | 7 | 0.26 | 13 | 7 | 0.26 |
| Negative | 20 | 5 | 20 | 5 | ||
| Stage |
| |||||
| T2 | 17 | 9 | 0.20 | 18 | 8 |
0.38 |
| T3 | 6 | 1 | 5 | 2 | ||
| T4 | 10 | 2 | 10 | 2 | ||
| Nodal status |
| |||||
| Positive | 28 | 11 | 0.55 | 28 | 11 | 0.55 |
| Negative | 5 | 1 | 5 | 1 | ||